SKINMEDICON: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SKINMEDICON
Largest movements
- Tangible fixed assets +€3.1m
up €3.1m (+63.4%), from €5.0m to €8.1m
of which Land and buildings: +€3.1m
- Cash +€681,340
up €681,340 (+1,165%), from €58,484 to €739,825
mainly Other debts (+€2.0m) and Debts after one year (+€1.8m)
- Other debts +€2.0m
up €2.0m (+186%), from €1.1m to €3.0m
- Debts after one year +€1.8m
up €1.8m (+55.1%), from €3.3m to €5.1m
- Reserves -€275,000
down €275,000 (-59.4%), from €463,000 to €188,000
- Current portion of long-term debt +€109,990
up €109,990 (+60.7%), from €181,055 to €291,045
- Trade debts +€103,379
up €103,379 (+263%), from €39,352 to €142,731
- Depreciation +€142,162
up €142,162 (+222%), from €64,175 to €206,337
- Gross operating margin +€142,160
up €142,160 (+51.7%), from €274,854 to €417,014
- Financial charges +€74,130
up €74,130 (+79.1%), from €93,775 to €167,905
- Taxes -€13,261
down €13,261 (-89.1%), from €14,890 to €1,629
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,186,247 | €9,006,025 | +€3.8m | +73.7% |
| Fixed assets | 21/28 | €4,953,173 | €8,091,498 | +€3.1m | +63.4% |
| Tangible fixed assets | 22/27 | €4,953,173 | €8,091,498 | +€3.1m | +63.4% |
| Land and buildings | 22 | €4,952,985 | €8,091,498 | +€3.1m | +63.4% |
| Furniture and vehicles | 24 | €189 | €0 | -€189 | -100% |
| Current assets | 29/58 | €233,074 | €914,526 | +€681,453 | +292% |
| Amounts receivable within one year | 40/41 | €172,928 | €172,787 | -€141 | -0.1% |
| Trade receivables | 40 | €68,430 | €106,946 | +€38,516 | +56.3% |
| Other amounts receivable | 41 | €104,498 | €65,840 | -€38,657 | -37.0% |
| Cash at bank and in hand | 54/58 | €58,484 | €739,825 | +€681,340 | +1,165% |
| Deferred charges and accrued income | 490/1 | €1,662 | €1,915 | +€253 | +15.2% |
| Total equity and liabilities | 10/49 | €5,186,247 | €9,006,025 | +€3.8m | +73.7% |
| Equity | 10/15 | €585,290 | €341,924 | -€243,366 | -41.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €463,000 | €188,000 | -€275,000 | -59.4% |
| Distributable reserves | 133 | €463,000 | €188,000 | -€275,000 | -59.4% |
| Profit (loss) carried forward | 14 | €103,690 | €135,324 | +€31,634 | +30.5% |
| Amounts payable | 17/49 | €4,600,957 | €8,664,101 | +€4.1m | +88.3% |
| Amounts payable after more than one year | 17 | €3,289,040 | €5,100,524 | +€1.8m | +55.1% |
| Financial debts | 170/4 | €3,289,040 | €5,100,524 | +€1.8m | +55.1% |
| Amounts payable within one year | 42/48 | €1,311,917 | €3,501,492 | +€2.2m | +167% |
| Current portion of amounts payable after more than one year | 42 | €181,055 | €291,045 | +€109,990 | +60.7% |
| Trade debts | 44 | €39,352 | €142,731 | +€103,379 | +263% |
| Suppliers | 440/4 | €39,352 | €142,731 | +€103,379 | +263% |
| Taxes, remuneration and social security | 45 | €27,368 | €19,308 | -€8,059 | -29.4% |
| Taxes | 450/3 | €20,011 | €19,308 | -€703 | -3.5% |
| Remuneration and social security | 454/9 | €7,356 | €0 | -€7,356 | -100% |
| Other amounts payable | 47/48 | €1,064,142 | €3,048,407 | +€2.0m | +186% |
| Accrued charges and deferred income | 492/3 | - | €62,085 | +€62,085 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €64,175 | €206,337 | +€142,162 | +222% |
| Other operating charges | 640/8 | €10,124 | €10,240 | +€115 | +1.1% |
| Gross operating margin | 9900 | €274,854 | €417,014 | +€142,160 | +51.7% |
| Operating profit (loss) | 9901 | €200,555 | €200,438 | -€117 | -0.1% |
| Financial income | 75/76B | €0 | €730 | +€730 | +260,743% |
| Recurring financial income | 75 | €0 | €730 | +€730 | +260,743% |
| Financial charges | 65/66B | €93,775 | €167,905 | +€74,130 | +79.1% |
| Recurring financial charges | 65 | €93,775 | €167,905 | +€74,130 | +79.1% |
| Profit (loss) for the period before taxes | 9903 | €106,780 | €33,263 | -€73,517 | -68.8% |
| Income taxes | 67/77 | €14,890 | €1,629 | -€13,261 | -89.1% |
| Profit (loss) for the period | 9904 | €91,890 | €31,634 | -€60,257 | -65.6% |
| Profit (loss) for the period to be appropriated | 9905 | €91,890 | €31,634 | -€60,257 | -65.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.